Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.

<h4>Objectives</h4>DMBT is an antibacterial pattern recognition and scavenger receptor. In this study, we analyzed the role of DMBT1 single nucleotide polymorphisms (SNPs) regarding inflammatory bowel disease (IBD) susceptibility and examined their functional impact on transcription fact...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julia Diegelmann, Darina Czamara, Emmanuelle Le Bras, Eva Zimmermann, Torsten Olszak, Andrea Bedynek, Burkhard Göke, Andre Franke, Jürgen Glas, Stephan Brand
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c33b4fcd095842d982dc5b509339a64f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c33b4fcd095842d982dc5b509339a64f
record_format dspace
spelling oai:doaj.org-article:c33b4fcd095842d982dc5b509339a64f2021-11-18T08:48:22ZIntestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.1932-620310.1371/journal.pone.0077773https://doaj.org/article/c33b4fcd095842d982dc5b509339a64f2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24223725/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>DMBT is an antibacterial pattern recognition and scavenger receptor. In this study, we analyzed the role of DMBT1 single nucleotide polymorphisms (SNPs) regarding inflammatory bowel disease (IBD) susceptibility and examined their functional impact on transcription factor binding and downstream gene expression.<h4>Methods</h4>Seven SNPs in the DMBT1 gene region were analyzed in 2073 individuals including 818 Crohn's disease (CD) patients and 972 healthy controls in two independent case-control panels. Comprehensive epistasis analyses for the known CD susceptibility genes NOD2, IL23R and IL27 were performed. The influence of IL23R variants on DMBT1 expression was analyzed. Functional analysis included siRNA transfection, quantitative PCR, western blot, electrophoretic mobility shift and luciferase assays.<h4>Results</h4>IL-22 induces DMBT1 protein expression in intestinal epithelial cells dependent on STAT3, ATF-2 and CREB1. IL-22 expression-modulating, CD risk-associated IL23R variants influence DMBT1 expression in CD patients and DMBT1 levels are increased in the inflamed intestinal mucosa of CD patients. Several DMBT1 SNPs were associated with CD susceptibility. SNP rs2981804 was most strongly associated with CD in the combined panel (p = 3.0 × 10(-7), OR 1.42; 95% CI 1.24-1.63). All haplotype groups tested showed highly significant associations with CD (including omnibus P-values as low as 6.1 × 10(-18)). The most strongly CD risk-associated, non-coding DMBT1 SNP rs2981804 modifies the DNA binding sites for the transcription factors CREB1 and ATF-2 and the respective genomic region comprising rs2981804 is able to act as a transcriptional regulator in vitro. Intestinal DMBT1 expression is decreased in CD patients carrying the rs2981804 CD risk allele.<h4>Conclusion</h4>We identified novel associations of DMBT1 variants with CD susceptibility and discovered a novel functional role of rs2981804 in regulating DMBT1 expression. Our data suggest an important role of DMBT1 in CD pathogenesis.Julia DiegelmannDarina CzamaraEmmanuelle Le BrasEva ZimmermannTorsten OlszakAndrea BedynekBurkhard GökeAndre FrankeJürgen GlasStephan BrandPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e77773 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Julia Diegelmann
Darina Czamara
Emmanuelle Le Bras
Eva Zimmermann
Torsten Olszak
Andrea Bedynek
Burkhard Göke
Andre Franke
Jürgen Glas
Stephan Brand
Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
description <h4>Objectives</h4>DMBT is an antibacterial pattern recognition and scavenger receptor. In this study, we analyzed the role of DMBT1 single nucleotide polymorphisms (SNPs) regarding inflammatory bowel disease (IBD) susceptibility and examined their functional impact on transcription factor binding and downstream gene expression.<h4>Methods</h4>Seven SNPs in the DMBT1 gene region were analyzed in 2073 individuals including 818 Crohn's disease (CD) patients and 972 healthy controls in two independent case-control panels. Comprehensive epistasis analyses for the known CD susceptibility genes NOD2, IL23R and IL27 were performed. The influence of IL23R variants on DMBT1 expression was analyzed. Functional analysis included siRNA transfection, quantitative PCR, western blot, electrophoretic mobility shift and luciferase assays.<h4>Results</h4>IL-22 induces DMBT1 protein expression in intestinal epithelial cells dependent on STAT3, ATF-2 and CREB1. IL-22 expression-modulating, CD risk-associated IL23R variants influence DMBT1 expression in CD patients and DMBT1 levels are increased in the inflamed intestinal mucosa of CD patients. Several DMBT1 SNPs were associated with CD susceptibility. SNP rs2981804 was most strongly associated with CD in the combined panel (p = 3.0 × 10(-7), OR 1.42; 95% CI 1.24-1.63). All haplotype groups tested showed highly significant associations with CD (including omnibus P-values as low as 6.1 × 10(-18)). The most strongly CD risk-associated, non-coding DMBT1 SNP rs2981804 modifies the DNA binding sites for the transcription factors CREB1 and ATF-2 and the respective genomic region comprising rs2981804 is able to act as a transcriptional regulator in vitro. Intestinal DMBT1 expression is decreased in CD patients carrying the rs2981804 CD risk allele.<h4>Conclusion</h4>We identified novel associations of DMBT1 variants with CD susceptibility and discovered a novel functional role of rs2981804 in regulating DMBT1 expression. Our data suggest an important role of DMBT1 in CD pathogenesis.
format article
author Julia Diegelmann
Darina Czamara
Emmanuelle Le Bras
Eva Zimmermann
Torsten Olszak
Andrea Bedynek
Burkhard Göke
Andre Franke
Jürgen Glas
Stephan Brand
author_facet Julia Diegelmann
Darina Czamara
Emmanuelle Le Bras
Eva Zimmermann
Torsten Olszak
Andrea Bedynek
Burkhard Göke
Andre Franke
Jürgen Glas
Stephan Brand
author_sort Julia Diegelmann
title Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
title_short Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
title_full Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
title_fullStr Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
title_full_unstemmed Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
title_sort intestinal dmbt1 expression is modulated by crohn's disease-associated il23r variants and by a dmbt1 variant which influences binding of the transcription factors creb1 and atf-2.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/c33b4fcd095842d982dc5b509339a64f
work_keys_str_mv AT juliadiegelmann intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT darinaczamara intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT emmanuellelebras intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT evazimmermann intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT torstenolszak intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT andreabedynek intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT burkhardgoke intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT andrefranke intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT jurgenglas intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
AT stephanbrand intestinaldmbt1expressionismodulatedbycrohnsdiseaseassociatedil23rvariantsandbyadmbt1variantwhichinfluencesbindingofthetranscriptionfactorscreb1andatf2
_version_ 1718421286287310848